CN1305517C - Mastoproliferation treating medicine - Google Patents
Mastoproliferation treating medicine Download PDFInfo
- Publication number
- CN1305517C CN1305517C CNB2005100180151A CN200510018015A CN1305517C CN 1305517 C CN1305517 C CN 1305517C CN B2005100180151 A CNB2005100180151 A CN B2005100180151A CN 200510018015 A CN200510018015 A CN 200510018015A CN 1305517 C CN1305517 C CN 1305517C
- Authority
- CN
- China
- Prior art keywords
- parts
- weight portions
- medicine
- radix
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a medicine for treating hyperplasia of mammary glands, which is prepared from 12 to 60 weight portions of cadaver aspongopi, 10 to 50 weight portions of angelica, 9 to 36 weight portions of safflower, 3 to 10 weight portions of dragon blood, 30 to 240 weight portions of dandelion, 12 to 48 weight portions of stiff silkorm, 12 to 48 weight portions of spina gleditsiae, 10 to 36 weight portions of curcuma root, 15 to 75 weight portions of weeping forsythia capsule, 30 to 240 weight portions of prairie milk vetch, 12 to 50 weight portions of lightyellow sophora root, 12 to 48 weight portions of green tangerine peel, 5 to 30 weight portions of liquorice and 10 to 30 weight portions of chicken's gizzard-membrane. The raw material medicines are weighed according to the proportion and purified, impurities are removed, and then the mixture without impurities are dried, pulverized and sieved by an 80 to 100-mesh sieve so as to prepare the conventional required medicine forms, namely the medicine for treating hyperplasia of mammary glands is prepared. The medicine for treating hyperplasia of mammary glands has the characteristics of scientific prescription, short course of treatment, obvious effect, low cost and difficult recurrence after diseases are healed, and is easy to prepare, popularize and apply.
Description
Technical field:
The present invention relates to a kind of Chinese medicine, particularly relate to a kind of medicine for the treatment of cyclomastopathy, belong to the field of Chinese medicines.
Background technology:
Cyclomastopathy is a kind ofly common easily to send out gynaecopathia multiple, it is to be caused by multiple factors such as people's physiological property and living environments, higher in 20-50 year age period intercurrent disease rate, its symptom is one-sided or a plurality of tough tuberositys of circular matter that vary in size take place the both sides breast, clinical manifestation be mammary swelling, bitterly, swollen, the breast flow liquid, suppurate; Cyclomastopathy, cyclomastopathy, mastitis, breast carcinoma, mastadenoma etc., during lighter menses breast pain is arranged, the sense of expanding, bring inconvenience to life, serious give patient and family cause serious harm, people's wealth is ended in defeat for both sidesboth suffer losses.Its physiological Mechanism mostly is temperament and interest internal injury, excessive fire in heart, endocrine disturbance, damp and hot Sheng and can not excessively become poison, moreover because people's life improves, the intravital nutritional labeling of patient is crossed Sheng, cause some residue and the secretions of unfavorable health is crossed and contained and not excessive, cause endocrine regulation, become evil long-pending poison, the most of patients irritability, warp in the impairment of QI, cause state of an illness outbreak, studies show that: the cyclomastopathy canceration rate is about 20%, and therefore the research to this disease receives much attention in recent years.
At present, doctor trained in Western medicine adopts hormone therapy to the treatment of cyclomastopathy more, though certain curative effect is arranged, side effect is big, and the patient is reluctant to adopt more.This disease of treatment by Chinese herbs has greater advantage, record as far back as existing this disease in Han dynasty, offspring's medical science has been carried out summary, analysis and the demonstration of system to symptom, pathology and the method for treatment of this disease, think that temperament and interest is not smooth, stagnation of QI due to depression of the liver be this sick main diseases because of, treat many contrary treatment gas and set about, and take into account disperse blood stasis and dredge collateral.It is main that present Chinese medicine mostly is clinical decoction to this treatment of conditions, has limited it and has applied.Though Chinese patent medicine asparagine, BUPIXIAO PIAN, RUKUAIXIAO PIAN, RUKANG PIAN, breast peace sheet etc. are arranged, and effect is undesirable, the course of treatment is long, easily recurrence, and clinical efficacy also remains further to be improved.
Summary of the invention:
The objective of the invention is: provide a kind of short treating period, the piece that takes effect, curative effect are good, cure the medicine that the back is difficult for the treatment cyclomastopathy of recurrence.
Technical scheme of the present invention is:
A kind of medicine for the treatment of cyclomastopathy, by following be that the crude drug of unit is formed: Aspongopus 12-60 part, Radix Angelicae Sinensis 10-50 part with the weight portion, Flos Carthami 9-36 part, Sanguis Draxonis 3-10 part, Herba Taraxaci 30-240 part, Bombyx Batryticatus 12-48 part, Spina Gleditsiae 12-48 part, Radix Curcumae 10-36 part, Fructus Forsythiae 15-75 part, Herba Violae 30-240 part, Radix Sophorae Flavescentis 12-50 part, Pericarpium Citri Reticulatae Viride 12-48 part.
The medicine of described treatment cyclomastopathy also contains Radix Glycyrrhizae 5-30 part, Endothelium Corneum Gigeriae Galli 10-30 part.
The optimization of C of the medicine of described treatment cyclomastopathy is: 60 parts of Aspongopuss, 50 parts of Radix Angelicae Sinensis, 36 parts on Flos Carthami, 10 parts of Sanguis Draxonis, 100 parts of Herba Taraxacis, 45 parts of Bombyx Batryticatus, 45 parts of Spina Gleditsiae, 36 parts of Radix Curcumaes, 50 parts of Fructus Forsythiaes, 100 parts of Herba Violaes, 50 parts of Radix Sophorae Flavescentiss, 45 parts on Pericarpium Citri Reticulatae Viride, 20 parts in Radix Glycyrrhizae, 20 parts of Endothelium Corneum Gigeriae Galli.
The optimum formula of the medicine of described treatment cyclomastopathy is: 60 parts of Aspongopuss, 50 parts of Radix Angelicae Sinensis, 36 parts on Flos Carthami, 10 parts of Sanguis Draxonis, 120 parts of Herba Taraxacis, 45 parts of Bombyx Batryticatus, 45 parts of Spina Gleditsiae, 36 parts of Radix Curcumaes, 50 parts of Fructus Forsythiaes, 120 parts of Herba Violaes, 50 parts of Radix Sophorae Flavescentiss, 45 parts on Pericarpium Citri Reticulatae Viride, 20 parts in Radix Glycyrrhizae, 20 parts of Endothelium Corneum Gigeriae Galli.
Positive beneficial effect of the present invention is:
1. the medicine of treatment cyclomastopathy of the present invention, scientific formulation is reasonable, has short treating period, a piece that takes effect, and it is few to spend, and cures the back and is difficult for advantages such as recurrence.
2. the medicine of treatment cyclomastopathy of the present invention is compared with the asparagine on the market, and is more obvious than the curative effect of asparagine, faster; It is compared with BUPIXIAO PIAN, and is more obvious than BUPIXIAO PIAN curative effect, quick; It is compared with breast peace sheet, and littler than the side effect of breast peace sheet, curative effect is more thorough.
3. the medicine of treatment cyclomastopathy of the present invention can be prepared into conventional various dosage forms, satisfies all kinds of patients' demand.
We are monarch drug with Aspongopus, Radix Angelicae Sinensis, Flos Carthami, Sanguis Draxonis, Herba Taraxaci, Bombyx Batryticatus, Spina Gleditsiae, Radix Curcumae, have benefiting QI for activating blood circulation, the meridians of promoting blood circulation, and the antiinflammatory blood stasis dispelling, removing food stagnancyization stagnates, and strengthens the human quality, the effect of endocrine regulation; The compatibility ministerial drug: Fructus Forsythiae, Herba Violae, Radix Sophorae Flavescentis, Pericarpium Citri Reticulatae Viride, can reach dispel burning, pathogenic fire reducing of heat clearing away and relieve internal heat, increase internal recycle, help health and act on normally; Attached with the adjuvant drug Radix Glycyrrhizae, make the drug effect performance of various medicines more abundant, thoroughly dispel source of disease; Add the messenger drug Endothelium Corneum Gigeriae Galli, make people's Appetitive stomachic, promoting digestion and removing stagnation, disease-relieving and physique enhancing is arranged, orectic effect.
Clinical and experimental study:
A: case is selected:
Select 40 routine cyclomastopathy patients, minimum 13 years old of age, maximum 55 years old, 35 years old mean age, average course of disease 2.5 years, their majority are mastopathy such as the mastitis that come out with inspect by instrument in County Hospital, cyclomastopathy, and it is undesirable that medicine of opening with outpatient service and the medicine of buying other are taken the back effect, take the cured substance of treatment cyclomastopathy of the present invention, and cure the difficult recurrence in back.
B: administrated method:
1: with the low dose of decoction of the medicine of treatment cyclomastopathy of the present invention, once a day, three days one pair of medicines, two courses of treatment Monday.Fast person takes effect a course of treatment, and slow person takes effect two courses of treatment.
2: powder or capsule with the medicine of treatment cyclomastopathy of the present invention are treated, once a day, and each 10-30g, two months one courses of treatment.Fast person takes effect fortnight, and slow person took effect in one month.
C: curative effect determinate standard:
1. recovery from illness: with after we treatment one or two course of treatment, the distending pain of the breast before the treatment, lump and sense of discomfort disappear, and spirit, diet, menstrual period are normal, and keep three months or more than half a year, breast does not have lump and fully recovers painless all the genus;
2. effective: after using we to treat one or two course of treatment, the patient feels that lump in breast dwindles, and mastalgia alleviates, and does not have pain menstrual period.Proof we have no adverse reaction, and is effectively.
3. produce effects: after the patient took we, lump in breast dwindled, pain relief, and menstrual period, pain also alleviated, and diet increases and is normal, and emotion, spirit, thought, mood are normal, are improvement.
4. invalid: the patient takes we after course of treatment, and original state of an illness does not alleviate at all, diet, mood not as treatment before, it is invalid then to be considered as, up to now none example still also.
D: therapeutic outcome:
| Case (80) | Cure | Effectively | Produce effects | Invalid |
| Number (people) | 66 | 10 | 4 | 0 |
| Ratio (%) | 82.5 | 12.5 | 5.0 | - |
From above therapeutic outcome as can be seen: the clinical drug of treatment cyclomastopathy of the present invention is effective, can satisfy the requirement of extensive patients.
The specific embodiment:
Embodiment one: a kind of medicine for the treatment of cyclomastopathy, by following be that the crude drug of unit is formed 12 parts of Aspongopuss with the weight portion, 10 parts of Radix Angelicae Sinensis, 9 parts on Flos Carthami, 3 parts of Sanguis Draxonis, 30 parts of Herba Taraxacis, 12 parts of Bombyx Batryticatus, 12 parts of Spina Gleditsiae, 10 parts of Radix Curcumaes, 15 parts of Fructus Forsythiaes, 30 parts of Herba Violaes, 12 parts of Radix Sophorae Flavescentiss, 12 parts on Pericarpium Citri Reticulatae Viride, 5 parts in Radix Glycyrrhizae, 10 parts of Endothelium Corneum Gigeriae Galli.
This treatment cyclomastopathy medicine processing method: with above-mentioned bulk drugs purification, roguing, oven dry, pulverizing, cross the 80-100 mesh sieve, make regular dosage form, as be powder, or be pill, or be capsule, or be water preparation.
Embodiment two: the dosage form of present embodiment medicine processing method and medicine is with embodiment one, and something in common does not repeat, and difference is: a kind of medicine for the treatment of cyclomastopathy, by following be that the crude drug of unit is formed 60 parts of Aspongopuss, 50 parts of Radix Angelicae Sinensis with the weight portion, 36 parts on Flos Carthami, 10 parts of Sanguis Draxonis, 240 parts of Herba Taraxacis, 48 parts of Bombyx Batryticatus, 48 parts of Spina Gleditsiae, 36 parts of Radix Curcumaes, 75 parts of Fructus Forsythiaes, 240 parts of Herba Violaes, 50 parts of Radix Sophorae Flavescentiss, 48 parts on Pericarpium Citri Reticulatae Viride, 30 parts in Radix Glycyrrhizae, 30 parts of Endothelium Corneum Gigeriae Galli.
Embodiment three: the dosage form of present embodiment medicine processing method and medicine is with embodiment one, and something in common does not repeat, and difference is: a kind of medicine for the treatment of cyclomastopathy, by following be that the crude drug of unit is formed 60 parts of Aspongopuss, 50 parts of Radix Angelicae Sinensis with the weight portion, 36 parts on Flos Carthami, 10 parts of Sanguis Draxonis, 100 parts of Herba Taraxacis, 45 parts of Bombyx Batryticatus, 45 parts of Spina Gleditsiae, 36 parts of Radix Curcumaes, 50 parts of Fructus Forsythiaes, 100 parts of Herba Violaes, 50 parts of Radix Sophorae Flavescentiss, 45 parts on Pericarpium Citri Reticulatae Viride, 20 parts in Radix Glycyrrhizae, 20 parts of Endothelium Corneum Gigeriae Galli.
Embodiment four: the dosage form of present embodiment medicine processing method and medicine is with embodiment one, and something in common does not repeat, and difference is: a kind of medicine for the treatment of cyclomastopathy, by following be that the crude drug of unit is formed 60 parts of Aspongopuss, 50 parts of Radix Angelicae Sinensis with the weight portion, 36 parts on Flos Carthami, 10 parts of Sanguis Draxonis, 120 parts of Herba Taraxacis, 45 parts of Bombyx Batryticatus, 45 parts of Spina Gleditsiae, 36 parts of Radix Curcumaes, 50 parts of Fructus Forsythiaes, 120 parts of Herba Violaes, 50 parts of Radix Sophorae Flavescentiss, 45 parts on Pericarpium Citri Reticulatae Viride, 20 parts in Radix Glycyrrhizae, 30 parts of Endothelium Corneum Gigeriae Galli.
Embodiment five: the dosage form of present embodiment medicine processing method and medicine is with embodiment one, and something in common does not repeat, and difference is: a kind of medicine for the treatment of cyclomastopathy, by following be that the crude drug of unit is formed 50 parts of Aspongopuss, 50 parts of Radix Angelicae Sinensis with the weight portion, 30 parts on Flos Carthami, 10 parts of Sanguis Draxonis, 100 parts of Herba Taraxacis, 40 parts of Bombyx Batryticatus, 40 parts of Spina Gleditsiae, 30 parts of Radix Curcumaes, 50 parts of Fructus Forsythiaes, 100 parts of Herba Violaes, 50 parts of Radix Sophorae Flavescentiss, 40 parts on Pericarpium Citri Reticulatae Viride, 20 parts in Radix Glycyrrhizae, 20 parts of Endothelium Corneum Gigeriae Galli.
Embodiment six: the dosage form of present embodiment medicine processing method and medicine is with embodiment one, and something in common does not repeat, and difference is: a kind of medicine for the treatment of cyclomastopathy, by following be that the crude drug of unit is formed 12 parts of Aspongopuss, 10 parts of Radix Angelicae Sinensis with the weight portion, 9 parts on Flos Carthami, 3 parts of Sanguis Draxonis, 30 parts of Herba Taraxacis, 12 parts of Bombyx Batryticatus, 12 parts of Spina Gleditsiae, 10 parts of Radix Curcumaes, 15 parts of Fructus Forsythiaes, 30 parts of Herba Violaes, 12 parts of Radix Sophorae Flavescentiss, 12 parts on Pericarpium Citri Reticulatae Viride, 5 parts in Radix Glycyrrhizae, 10 parts of Endothelium Corneum Gigeriae Galli.
Embodiment seven: the dosage form of present embodiment medicine processing method and medicine is with embodiment one, and something in common does not repeat, and difference is: a kind of medicine for the treatment of cyclomastopathy, by following be that the crude drug of unit is formed 40 parts of Aspongopuss, 40 parts of Radix Angelicae Sinensis with the weight portion, 20 parts on Flos Carthami, 5 parts of Sanguis Draxonis, 200 parts of Herba Taraxacis, 30 parts of Bombyx Batryticatus, 20 parts of Spina Gleditsiae, 25 parts of Radix Curcumaes, 50 parts of Fructus Forsythiaes, 180 parts of Herba Violaes, 35 parts of Radix Sophorae Flavescentiss, 25 parts on Pericarpium Citri Reticulatae Viride, 15 parts in Radix Glycyrrhizae, 18 parts of Endothelium Corneum Gigeriae Galli.
Embodiment eight: the dosage form of present embodiment medicine processing method and medicine is with embodiment one, and something in common does not repeat, and difference is: a kind of medicine for the treatment of cyclomastopathy, by following be that the crude drug of unit is formed 35 parts of Aspongopuss, 25 parts of Radix Angelicae Sinensis with the weight portion, 25 parts on Flos Carthami, 8 parts of Sanguis Draxonis, 155 parts of Herba Taraxacis, 35 parts of Bombyx Batryticatus, 30 parts of Spina Gleditsiae, 35 parts of Radix Curcumaes, 45 parts of Fructus Forsythiaes, 95 parts of Herba Violaes, 40 parts of Radix Sophorae Flavescentiss, 35 parts on Pericarpium Citri Reticulatae Viride, 20 parts in Radix Glycyrrhizae, 25 parts of Endothelium Corneum Gigeriae Galli.
Claims (4)
1. medicine for the treatment of cyclomastopathy, it is characterized in that: with the weight portion is unit, contains Aspongopus 12-60 part, Radix Angelicae Sinensis 10-50 part, Flos Carthami 9-36 part, Sanguis Draxonis 3-10 part, Herba Taraxaci 30-240 part, Bombyx Batryticatus 12-48 part, Spina Gleditsiae 12-48 part, Radix Curcumae 10-36 part, Fructus Forsythiae 15-75 part, Herba Violae 30-240 part, Radix Sophorae Flavescentis 12-50 part, Pericarpium Citri Reticulatae Viride 12-48 part.
2. the medicine of treatment cyclomastopathy according to claim 1 is characterized in that: also contain Radix Glycyrrhizae 5-30 part, Endothelium Corneum Gigeriae Galli 10-30 part.
3. the medicine of treatment cyclomastopathy according to claim 1 and 2 is characterized in that: by following be that the crude drug of unit is formed 60 parts of Aspongopuss with the weight portion, 50 parts of Radix Angelicae Sinensis, 36 parts on Flos Carthami, 10 parts of Sanguis Draxonis, 100 parts of Herba Taraxacis, 45 parts of Bombyx Batryticatus, 45 parts of Spina Gleditsiae, 36 parts of Radix Curcumaes, 50 parts of Fructus Forsythiaes, 100 parts of Herba Violaes, 50 parts of Radix Sophorae Flavescentiss, 45 parts on Pericarpium Citri Reticulatae Viride, 20 parts in Radix Glycyrrhizae, 20 parts of Endothelium Corneum Gigeriae Galli.
4. the medicine of treatment cyclomastopathy according to claim 1 and 2 is characterized in that: by following be that the crude drug of unit is formed 60 parts of Aspongopuss with the weight portion, 50 parts of Radix Angelicae Sinensis, 36 parts on Flos Carthami, 10 parts of Sanguis Draxonis, 120 parts of Herba Taraxacis, 45 parts of Bombyx Batryticatus, 45 parts of Spina Gleditsiae, 36 parts of Radix Curcumaes, 50 parts of Fructus Forsythiaes, 120 parts of Herba Violaes, 50 parts of Radix Sophorae Flavescentiss, 45 parts on Pericarpium Citri Reticulatae Viride, 20 parts in Radix Glycyrrhizae, 20 parts of Endothelium Corneum Gigeriae Galli.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100180151A CN1305517C (en) | 2005-09-20 | 2005-09-20 | Mastoproliferation treating medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100180151A CN1305517C (en) | 2005-09-20 | 2005-09-20 | Mastoproliferation treating medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1739765A CN1739765A (en) | 2006-03-01 |
| CN1305517C true CN1305517C (en) | 2007-03-21 |
Family
ID=36092390
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100180151A Expired - Fee Related CN1305517C (en) | 2005-09-20 | 2005-09-20 | Mastoproliferation treating medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1305517C (en) |
-
2005
- 2005-09-20 CN CNB2005100180151A patent/CN1305517C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1739765A (en) | 2006-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101391077B (en) | Preparation method of traditional Chinese medicine for treating chronic pelvic inflammatory disease | |
| CN100444888C (en) | The Chinese herbal medicinal pills for treatment of hepatitis B and liver cancer | |
| CN102488784A (en) | Traditional Chinese medicine composition for treating low back pain | |
| CN101530516B (en) | Chinese medicament for treating appendicitis | |
| CN1927362A (en) | Traditional Chinese powder medicine for treating toothache | |
| CN1305517C (en) | Mastoproliferation treating medicine | |
| CN103054952A (en) | Medicine for treating periodontitis and preparation method thereof | |
| CN106389550A (en) | Traditional Chinese medicine for treating herpes zoster | |
| CN106377716A (en) | Traditional Chinese medicine composition for treating dysentery | |
| CN1264591A (en) | Medicine for treating psoriasis and preparing process thereof | |
| CN1305510C (en) | Medicine for treating intractable fever | |
| CN102319330B (en) | Traditional Chinese medicine cataplasma for treating hyperosteogeny and preparation method thereof | |
| CN101204554B (en) | Medicaments composite for stomach illness and preparation method thereof | |
| CN1270755C (en) | Pharmaceutical composition for treating rheumatic arthritis and rheumatoid arthritis | |
| CN109260416A (en) | It is a kind of for alleviating the spontaneous heating ooze medicine paste of qi stagnation and blood stasis type pain in back and loin | |
| CN113244363B (en) | Traditional Chinese medicine cake moxibustion for orthopedics department as well as preparation method and application thereof | |
| CN102755598B (en) | Medicine for treating acute gouty arthritis and preparation method thereof | |
| CN1052908C (en) | "Chanhouning" and its preparation method | |
| CN101954043A (en) | Medicament for treating hyperosteogeny and preparation method thereof | |
| CN101983681A (en) | Medicament for treating abnormal leucorrhea | |
| CN1927349A (en) | Traditional Chinese medicine for treating rheumatism and its preparing process | |
| CN106266391A (en) | A kind of medicine for fat-eliminating slimming | |
| CN103070998B (en) | Externally-applied plaster for curing pain of rheumatic joints | |
| CN105582223A (en) | External traditional Chinese medicine for treating acute and chronic traumatic injuries | |
| CN105250641A (en) | Traditional Chinese medicine composition for treating rheumatism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070321 Termination date: 20091020 |